Istaroxime
| CAS No. | 203737-93-3 | Cat. No. | BCP07927 |
| Name | Istaroxime | ||
| Synonyms | PST-2744; PST 2744; PST2744; | ||
| Formula | C21H32N2O3 | M. Wt | 360.49 |
| Description | Istaroxime is a positive inotropic agent that mediates its action through inhibition of sodium/potassium adenosine triphosphatase (Na+/K+ ATPase). Istaroxime is an investigational drug originally patented and developed by the italian pharmaceutical company Sigma-Tau. Istaroxime is now under development for treatment of acute decompensated heart failure by CVie Therapeutics. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | ATPase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.